-
The power of arts‐based film interventions to encourage Black blood donors Transfusion (IF 2.5) Pub Date : 2024-09-23 Richard Mills, Abiola Okubanjo, Natasha Acheampong, Mark Croucher, Nadine Eaton, Altaf Kazi, Emanuele di Angelantonio, Angela Wood, Barbara Masser, Eamonn Ferguson
BackgroundBlood services must consider innovative ways to encourage more Black people to donate to enhance the efficacy of treatments. We evaluate how two innovative arts‐based approaches (co‐designed and locally produced films and a large‐scale Marvel Studios'/NHSBT collaboration) can achieve this by generalizing to a wider audience from their target audiences.Study Design and MethodsFour co‐designed
-
Storage properties of platelet concentrates from umbilical cord blood prepared using three different methods Transfusion (IF 2.5) Pub Date : 2024-09-21 Valeria Cortesi, Enrico Lopriore, Giacomo Cavallaro, Ido J. Bontekoe, Pieter F. van der Meer, Susanna Fustolo‐Gunnink, Genny Raffaeli, Stefano Ghirardello, Thomas R. L. Klei
BackgroundThrombocytopenia, common in preterm newborns, may increase bleeding risk and is often treated with transfusions. Recent studies reveal that transfusing platelets at a high threshold worsens outcomes, possibly due to a “developmental mismatch” between adult‐derived platelets and neonatal hemostatic system. Cord blood‐derived platelet concentrates (CBPCs) could be an alternative for newborns
-
Supporting the expansion of organ transplant: Transfusion services handle the details Transfusion (IF 2.5) Pub Date : 2024-09-21 Jessica Poisson
-
Racial and ethnic differences in transfusion rates in adolescent scoliosis surgery: Preoperative anemia as a mediator of disparity Transfusion (IF 2.5) Pub Date : 2024-09-21 Sophie Fisher, Stanford Chihuri, Jean Guglielminotti, Guohua Li, Lisa Eisler
BackgroundPediatric patients from minoritized racial and ethnic groups receive red blood cell (RBC) transfusions more frequently while undergoing major surgical procedures. Our objective was to identify the contribution of preoperative anemia to racial and ethnic differences in RBC transfusion rates in adolescent spine surgery.Study Design and MethodsThis is a multicenter, retrospective cohort study
-
Recruiting blood donors to the Canadian Blood Services Stem Cell Registry: A feasibility assessment Transfusion (IF 2.5) Pub Date : 2024-09-19 Gaganvir Parmar, Meagan Green, Kathy Ganz, Matthew D. Seftel, David S. Allan
BackgroundAllogeneic hematopoietic cell transplantation remains limited when stem cell registrants cannot be contacted, are not medically fit, are unavailable, or unwilling to proceed. In a recent report, registrants who were prior blood donors were more likely to be available for donation. In this study, we analyzed extent to which recruiting blood donors to the Canadian Blood Services Stem Cell Registry
-
Comparison of manual titrations to automated microplate and gel titration assays used in the screening of blood donors for production of Low‐Titer O Whole Blood Transfusion (IF 2.5) Pub Date : 2024-09-19 Michael D. Orr, Brian G. Casleton, Olivia R. Garcia
BackgroundThe popularity of Low‐Titer O Whole Blood (LTOWB) for treating trauma patients requires that donor centers and transfusion services make decisions on what titer testing capabilities to institute and an appropriate titer level threshold. This study compared the titer results determined by four methods to find a rate of agreement.Study Design and MethodsIsohemagglutinin titers were tested on
-
The development and evanescence of red blood cell antibodies after transfusion: A multi‐institutional prospective study in Japan Transfusion (IF 2.5) Pub Date : 2024-09-17 Chiaki Yamada, Takaaki Ono, Kaede Ino, Naoki Nemoto, Takahito Shinba, Hiroaki Furumaki, Hiroki Shibata, Keiko Ishizuka, Naotomo Yamada, Hideaki Matsuura, Yumiko Izuhara, Harumi Fujihara, Hitoshi Minamiguchi
BackgroundDespite several reports on red blood cell (RBC) alloimmunization, the actual prevalence and factors contributing to RBC alloimmunization in transfused patients remain poorly investigated. We examined the association between clinical factors and the development and evanescence of RBC antibodies after transfusion.Study Design and MethodsEach participating institution performed antibody screens
-
Use of low titer O whole blood in infants and young children undergoing cardiac surgery with cardiopulmonary bypass Transfusion (IF 2.5) Pub Date : 2024-09-13 Massimo Griselli, Sameh M. Said, Philip C. Spinella, Michael Evans, Claudia S. Cohn, Nitasha Joyner, Martina Richtsfeld, Kayla Fahey‐Arndt, Julie Welbig, Greg Beilman, Nicole D. Zantek, Marie E. Steiner
BackgroundLow titer group O whole blood (LTOWB) is commonly used for severe bleeding in trauma patients. LTOWB may also benefit young children requiring cardiac surgery with cardiopulmonary bypass (CPB) at risk of severe bleeding.Study Design and MethodsIn this retrospective study, children <2 years old who underwent cardiac surgery with CPB were included. Comparisons were performed between those receiving
-
A deep learning approach to prediction of blood group antigens from genomic data Transfusion (IF 2.5) Pub Date : 2024-09-13 Camous Moslemi, Susanne Sækmose, Rune Larsen, Thorsten Brodersen, Jakob T. Bay, Maria Didriksen, Kaspar R. Nielsen, Mie T. Bruun, Joseph Dowsett, Khoa M. Dinh, Christina Mikkelsen, Kati Hyvärinen, Jarmo Ritari, Jukka Partanen, Henrik Ullum, Christian Erikstrup, Sisse R. Ostrowski, Martin L. Olsson, Ole B. Pedersen
BackgroundDeep learning methods are revolutionizing natural science. In this study, we aim to apply such techniques to develop blood type prediction models based on cheap to analyze and easily scalable screening array genotyping platforms.MethodsCombining existing blood types from blood banks and imputed screening array genotypes for ~111,000 Danish and 1168 Finnish blood donors, we used deep learning
-
-
-
Anti‐donor antibody neutralization by donor type red cell challenge: A novel therapeutic strategy in refractory post‐transplant pure red cell aplasia Transfusion (IF 2.5) Pub Date : 2024-09-09 Mayank Soni, Shubhank Goyal, Narendra Agrawal, Tribikram Panda
-
-
Building a local rare blood registry from scratch: A success story Transfusion (IF 2.5) Pub Date : 2024-09-09 Denise Brunetta, Lhais Helenne Santos, Tie Costa, Francisca Lariza Moura, Josiana Cruz, Nagela Oliveira, Maria Isaaquilelle Oliveira, Claudia Monteiro, Franklin Jose Santos, Luciana Maria Carlos
-
Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United States Transfusion (IF 2.5) Pub Date : 2024-09-09 Jeremy W. Jacobs, Garrett S. Booth, Kenneth J. Moise, Brian D. Adkins, Sara Bakhtary, Ross M. Fasano, Ruchika Goel, Hannah D. Hinton, Sadia A. Laghari, Laura D. Stephens, Christopher A. Tormey, Elizabeth P. Crowe, Evan M. Bloch, Elizabeth A. Abels
BackgroundHemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibody‐mediated destruction of fetal/neonatal red blood cells (RBCs). While the pathophysiology has been well‐characterized, the clinical and laboratory monitoring practices are inconsistent.MethodsWe surveyed 103 US institutions to characterize laboratory testing practices for individuals with fetuses at risk of
-
Survey of pediatric massive transfusion protocol practice at United States level I trauma centers: An AABB Pediatric Transfusion Medicine Subsection study Transfusion (IF 2.5) Pub Date : 2024-09-09 Brian D. Adkins, Daniel K. Noland, Jeremy W. Jacobs, Garrett S. Booth, Denise Malicki, Louise Helander, Cyril Jacquot, Gina Buscema, Ruchika Goel, Jennifer Andrews, Lani Lieberman
BackgroundTrauma remains the leading cause of pediatric mortality in the United States. Although use of massive transfusion protocols (MTPs) in this population is widespread, optimal pediatric resuscitation is not well established. We sought to assess contemporary pediatric MTP practice in the United States.Study Design and MethodsA web‐based survey was designed by the Association for the Advancement
-
Keep ahead: A monthly roundup of key articles in other journals Transfusion (IF 2.5) Pub Date : 2024-09-06 Caitlin McOmish
-
Prehospital central venous catheters Transfusion (IF 2.5) Pub Date : 2024-08-31 Nicholas M. Studer, Jason R. Pickett, C. J. Winckler, William R. Smith, Andrew P. Cap, Cord W. Cunningham
KEY IDEAS The use of whole blood in the prehospital setting is increasing. Currently available intraosseous and peripheral venous catheters limit the flow of blood products and fluid during resuscitation. Central venous catheters can be effectively placed in the prehospital environment. Rapid, high‐volume infusion of blood products can be lifesaving.
-
Life‐threatening hemorrhage as defined by the critical administration threshold in nontraumatic critical bleeding: A descriptive observational study Transfusion (IF 2.5) Pub Date : 2024-08-30 Luke J. Matzek, Andrew C. Hanson, Phillip J. Schulte, Kimberly D. Cureton, Daryl J. Kor, Matthew A. Warner
BackgroundEvaluations of critical bleeding and massive transfusion have focused on traumatic hemorrhage. However, most critical bleeding in hospitalized patients occurs outside trauma. The purpose of this study was to provide an in‐depth description examining the critical administration threshold (CAT; ≥3 units red blood cells (RBCs) in a 1‐h period) occurrences in nontraumatic hemorrhage. This will
-
Acceptability of sexual history questions in a gender‐neutral risk assessment for blood donation Transfusion (IF 2.5) Pub Date : 2024-08-27 Yasmin Mowat, Bridget Haire, Barbara Masser, Veronica Hoad, Anita Heywood, Rachel Thorpe, Hamish McManus, John Kaldor, Skye McGregor
BackgroundCurrently in Australia, men are deferred from donating blood if they have had sex with another man within the past 3 months. However, a proposed gender‐neutral assessment (GNA) process will ask all donors questions about sex with new or multiple recent partners, with deferral based on responses to a question about anal sex. Understanding the acceptability of such questions among existing
-
Functional biomarkers for sickle cell disease Transfusion (IF 2.5) Pub Date : 2024-08-27 Yvette C. Tanhehco
-
Providing red blood cells to facilitate organ transplant via normothermic perfusion techniques: A single‐center experience Transfusion (IF 2.5) Pub Date : 2024-08-24 Elizabeth S. Allen, Laura D. Stephens, Nesinee Weber, Aleah L. Brubaker, Ken Hudson, Victor Pretorius, Gabriel Schnickel, Patricia M. Kopko
BackgroundNormothermic regional perfusion (NRP) and normothermic machine perfusion (NMP) are organ procurement and transport techniques that can improve organ quality, facilitate longer transport, and reduce postoperative complications, increasing organ availability and improving outcomes. NRP and NMP often require allogeneic red blood cells (RBCs). Our academic transfusion service began providing
-
The effectiveness of telephone surveys on the return of first‐time donors: A randomized controlled trial Transfusion (IF 2.5) Pub Date : 2024-08-21 Vanessa C. Marsano, Dirk Hasenclever, Reinhard Henschler
BackgroundThe management of blood supply depends, among other factors, on the effective remobilization of first‐time donors (FTDs). This study investigates the efficacy of telephone calls to increase second donation rates.Study Design and MethodsA randomized controlled trial was conducted on 418 first‐time blood donors. In the telephone group (TG, n = 206), men were contacted 9–10 and women 13–14 weeks
-
Massive fetomaternal hemorrhage from placental abruption presenting as weak‐D expression Transfusion (IF 2.5) Pub Date : 2024-08-19 Lindsey K. Durowoju, Rida A. Hasan, John R. Hess, Daniel E. Sabath, Andrew Bryan, Monica B. Pagano, Hamilton C. Tsang
-
-
Prediction of CD34+ hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+? Transfusion (IF 2.5) Pub Date : 2024-08-17 Sıdıka Gülkan Özkan, Ali Kimiaei, Seyedehtina Safaei, Tarık Ercan, Meral Sönmezoğlu, Gülderen Yanıkkaya Demirel, Sema Aktaş, Sinem Özdemir, Helin Serda Özalp, Hasan Atilla Özkan
BackgroundPeripheral blood‐derived hematopoietic stem cells (HSCs) are widely used for various adult stem cell transplants. To obtain sufficient HSCs from healthy volunteer donors during the apheresis process and ensure that the donors are exposed to fewer apheresis‐related side effects, calculation methods have been developed for the prediction of processed blood volume or CD34+ count. However, there
-
Correction to “Estimating Waiting Time for Compatible Blood: A Negative Binomial Approach” Transfusion (IF 2.5) Pub Date : 2024-08-17
-
Identification of a novel c.506A>C variant on the ABO*A1.02 allele in a Chinese individual Transfusion (IF 2.5) Pub Date : 2024-08-16 Yongkui Kong, Ming Shao, Huifang Jin, Qiankun Yang, Xianping Lyu
-
-
Simple formula for adjusted performance parameters in evaluation of diagnostic methods Transfusion (IF 2.5) Pub Date : 2024-08-15 Frederik Banch Clausen, Alberte Aspaas Lundquist, Emil Urhammer, Leif Kofoed Nielsen, Klaus Rieneck
-
When transfusion causes a splitting headache: A case report and rapid review of transfusion‐associated reversible cerebral vasoconstriction syndrome Transfusion (IF 2.5) Pub Date : 2024-08-14 Bobbie Pelham‐Webb, Yin Guo, Alejandra Ramirez, Evan Waldron, Valentina Emmanuele, Wendy Vargas, Justine Kahn, Elizabeth F. Stone
KEY IDEAS Reversible cerebral vasoconstriction syndrome (RCVS) is a rare and understudied transfusion reaction most commonly seen in adult females after correction of chronic, severe anemia. Transfusion‐associated RCVS (TA‐RCVS) typically presents with thunderclap headaches and one or more systemic (hypertension, nausea/vomiting) or neurologic (seizure, stroke, visual changes) symptoms within a week
-
Iron deficiency‐related symptoms in non‐anemic whole blood donors Transfusion (IF 2.5) Pub Date : 2024-08-14 J. Karregat, A. Meulenbeld, J. Abubakar, F. A. Quee, K. van den Hurk
IntroductionWhole blood donors are at increased risk for iron deficiency (ID). ID anemia is associated with several symptoms, such as fatigue, cognitive dysfunction, pica, and restless leg syndrome (RLS). However, it is unclear if these symptoms also occur when a donor has developed ID without anemia. This study aims to determine whether non‐anemic ID (NAID) is associated with the occurrence of ID‐related
-
Use of group a thawed plasma in emergency transfusions at a pediatric quaternary care center Transfusion (IF 2.5) Pub Date : 2024-08-14 Cyril Jacquot, Tahirah Jones, Burak Bahar, Julia Cabacar, Jennifer Webb, Yunchuan Delores Mo, Antoine Tavares da Souza, Meghan Delaney
BackgroundBalanced plasma/red blood cell transfusions have shown survival benefit in emergency scenarios. To improve plasma availability, we implemented 5‐day group A thawed plasma at our pediatric hospital in February 2021.Study Design and MethodsWe maintain thawed group A plasma units (5‐day shelf‐life) ready for immediate issue in the blood bank (since February 2021) and trauma code room (since
-
Keep ahead: A monthly roundup of key articles in other journals Transfusion (IF 2.5) Pub Date : 2024-08-14 Caitlin McOmish
-
Addressing platelet insecurity – A national call to action Transfusion (IF 2.5) Pub Date : 2024-08-12 Eric A. Gehrie, Pampee P. Young, Sridhar V. Basavaraju, Arthur W. Bracey, Andrew P. Cap, Liz Culler, Nancy M. Dunbar, Mary Homer, Iris Isufi, Rob Macedo, Tanya Petraszko, Glenn Ramsey, Christopher A. Tormey, Richard M. Kaufman, Edward L. Snyder
-
-
-
Implementing pathogen reduction technology while discontinuing blood donor deferral criteria for sexual risk behaviors: A simulation study Transfusion (IF 2.5) Pub Date : 2024-08-10 Marie‐Pier Domingue, Sheila F. O'Brien, Yves Grégoire, Marion C. Lanteri, Susan L. Stramer, Félix Camirand Lemyre, Antoine Lewin
BackgroundCombining pathogen reduction technology (PRT) with blood screening may alleviate concerns over the risk of transfusion‐transmitted infections (TTI) and support changes in blood donor selection to potentially increase blood availability. This study aimed to estimate the residual risk of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) transfusion‐transmission
-
Incidentally detected West Nile virus‐RNA positive blood donors do not harbor high titers of neutralizing antibodies Transfusion (IF 2.5) Pub Date : 2024-08-10 Silvia Meschi, Francesca Colavita, Giulia Matusali, Daniele Focosi, Fabrizio Maggi, Massimo Franchini
-
-
Correction to “Clinical data for intravenous iron – debunking the hype around hypersensitivity” Transfusion (IF 2.5) Pub Date : 2024-08-09
-
Efficacy and safety of novel freeze‐dried plasma products in a porcine combat casualty model Transfusion (IF 2.5) Pub Date : 2024-08-09 Frédérique Dufour‐Gaume, Vénétia Cardona, Audrey Bordone, Florent Montespan, Philippe Vest, Anne‐Margaux Legland, Nadira Frescaline, Nicolas Prat
BackgroundHemorrhagic shock is well documented as a leading cause of preventable fatalities among military casualties. During military operations plasma can be transfused while waiting for whole blood. This study was conducted to assess the safety and efficacy of two new freeze‐dried plasma formulations in a porcine model of traumatic hemorrhagic shock.Study Design and MethodsIn the face of species‐specific
-
Four novel ABO*B alleles associated with reduced B antigen expression Transfusion (IF 2.5) Pub Date : 2024-08-09 Yan Li, Liling Zhou, Wei Han, Zhaoze Ma, Chenlong Wang
-
Alloimmunization in myelodysplastic syndrome is associated with higher healthcare costs, longer hospitalizations, and increased mortality Transfusion (IF 2.5) Pub Date : 2024-08-07 Elisabet Viayna, Eric A. Gehrie, Christopher Blanchette
BackgroundTransfusion of red blood cells (RBC) is an important component of treatment for myelodysplastic syndromes (MDS). Patients receiving frequent transfusions are more likely to develop alloimmunization, an immune reaction to minor RBC antigens that increases the risk of complications including delayed hemolysis. Phenotypic matching is believed to reduce alloimmunization although rigorous evidence
-
Australian fresh frozen plasma audit: A National Blood Transfusion Committee and Blood Matters collaboration Transfusion (IF 2.5) Pub Date : 2024-08-06 Lisa Clarke, Ellen Maxwell, Trish Roberts, Linley Bielby
BackgroundThere is a paucity of high‐quality data to guide appropriate fresh frozen plasma transfusion with current recommendations based on consensus opinion. The limitations of the product and testing modalities are poorly understood with the rare but potentially serious side effects underappreciated. Combined this has resulted in the widespread misuse of FFP.Study Design and MethodsRetrospective
-
Use of half red blood cell units in oncology patients during severe shortages to extend hospital supply Transfusion (IF 2.5) Pub Date : 2024-08-05 Lefan Zhuang, Haoyue Shan, Dongyun Yang, Jennifer Woo, Shirong Wang, Alexander Garcia, Ryan Jackson, Shan Yuan
BackgroundThe COVID‐19 pandemic exerted an unprecedented impact on the blood supply from 2020 through 2022. As a result, throughout 2021 there were months our hospital had less than one‐day supply of type O RBCs. To meet transfusion needs, whole RBC units were split into half units and issued to stable, non‐bleeding patients. This single‐institution, retrospective study examines time intervals to subsequent
-
Novel RHD allele with c.487‐2A>G (IVS3‐2A>G) variant causing RhD negative phenotype Transfusion (IF 2.5) Pub Date : 2024-08-03 Yuli Zhu, Lihong Jiang, Zhihui Feng, Aiying Wang
-
Molecular communication between red blood cells of different phenotypes during blood storage in mice Transfusion (IF 2.5) Pub Date : 2024-08-03 James C. Zimring, Ariel M. Hay, Monika Dzieciatkowska, Angelo D'Alessandro
BackgroundThe cellular and molecular changes during red blood cell (RBC) storage that affect posttransfusion recovery (PTR) remain incompletely understood. We have previously reported that RBCs of different storage biology cross‐regulate each other when stored together (co‐storage cross‐regulation [CSCR]). However, the mechanism of CSCR is unclear. In the current study, we tested the hypothesis that
-
Current advances in 2024: A critical review of selected topics by the Association for the Advancement of Blood and Biotherapies (AABB) Clinical Transfusion Medicine Committee Transfusion (IF 2.5) Pub Date : 2024-08-01 Jacqueline N. Poston, Jennifer Andrews, Sumedha Arya, Stella T. Chou, Claudia Cohn, Mischa Covington, Elizabeth P. Crowe, Ruchika Goel, Gaurav K. Gupta, Richard L. Haspel, Aaron Hess, Tina S. Ipe, Jessica Jacobson, Jenna Khan, Mike Murphy, Kerry O'Brien, Monica B. Pagano, Anil K. Panigrahi, Eric Salazar, Nabiha H. Saifee, Moritz Stolla, Nicole D. Zantek, Alyssa Ziman, Ryan A. Metcalf
-
Optimizing damage control resuscitation through early patient identification and real‐time performance improvement Transfusion (IF 2.5) Pub Date : 2024-07-30 Daniela Schmulevich, Allyson M. Hynes, Shyam Murali, Andrew J. Benjamin, Jeremy W. Cannon
-
Real‐time performance improvement optimizes damage control resuscitation best practice adherence: Results of a pilot prospective observational study Transfusion (IF 2.5) Pub Date : 2024-07-27 Daniela Schmulevich, Zhi Geng, Sarah M. Joergensen, Nathaniel R. McLauchlan, Eric Winter, Alea Zone, Kathleen E. Bishop, Alyson Hinkle, Sara Holland, Pamela Z. Cacchione, Erin E. Fox, Benjamin S. Abella, Christopher L. Meador, Charles E. Wade, Allyson M. Hynes, Jeremy W. Cannon
BackgroundMaintaining balanced blood product ratios during damage control resuscitation (DCR) is independently associated with improved survival. We hypothesized that real‐time performance improvement (RT‐PI) would increase adherence to DCR best practice.Study Design and MethodsFrom December 2020–August 2021, we prospectively used a bedside RT‐PI tool to guide DCR in severely injured patients surviving
-
Prehospital transfusion of labile blood product using intraosseous perfusion with multi‐lumen extender: Why not? Transfusion (IF 2.5) Pub Date : 2024-07-26 J. Aloird, P. Bernard, O. Javaudin, M. Casse, M. Richez, J.‐B. Hitier, A. Sarda, F. Colleu, J. Boissier, J.‐P. Freiermuth
BackgroundFrench prehospital military medical teams are provided with labile blood products to effectively address hemorrhagic shock. In combat environment, standard good medical practice may limit efficacy of therapeutic goals regarding damage control resuscitation.Study Design and MethodsWe present here a case report describing the management of a soldier heavily wounded during a helicopter forward
-
Three novel Er blood group system alleles and insights from protein modeling Transfusion (IF 2.5) Pub Date : 2024-07-25 William J. Lane, Sunitha Vege, Helen H. Mah, Gorka Ochoa‐Garay, Christine Lomas‐Francis, Connie M. Westhoff
BackgroundThe Er blood group system was recently shown to be defined by PIEZO1. The system consists of high prevalence antigens Era, Er3, ERSA, and ERAMA; and low prevalence antigen Erb. Era/Erb are antithetical with Er(a−b+) defined by the ER*B allele [c.7180G>A p.(Gly2394Ser)]. A nonsense variant c.5289C>G p.(Tyr1763*) is associated with a predicted Ernull phenotype, and a missense variant c.7174G>A
-
A review of attitudes to urgent RhD‐positive transfusions in female patients and the risk for hemolytic disease of the fetus and newborn Transfusion (IF 2.5) Pub Date : 2024-07-24 Mark H. Yazer, Philip C. Spinella, John B. Holcomb, Sarah Horvath, Molly R. Sherwood, Stephen P. Emery, Julie C. Leonard, Christine M. Leeper
-
Anti‐HNA testing of allo‐exposed COVID‐19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti‐HNA antibody‐mediated transfusion‐related acute lung injury Transfusion (IF 2.5) Pub Date : 2024-07-24 Katarzyna Guz, Patrycja Łopacz, Małgorzata Uhrynowska, Karolina Piaskowska, Beata Szczepaniak, Magdalena Krzemienowska, Sylwia Purchla‐Szepioła, Anna Główka, Eliza Głodkowska‐Mrówka, Agnieszka Orzińska
BackgroundTransfusion‐related acute lung injury caused by antibodies against human neutrophil antigens (HNA) is a serious but rare complication associated with blood transfusion. The presence of such antibodies is most probable in donors with a transfusion/pregnancy history. During the COVID‐19 pandemic period convalescent plasma (CP) containing neutralizing antibodies against SARS‐CoV‐2 was widely
-
Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes Transfusion (IF 2.5) Pub Date : 2024-07-24 Ken Takigawa, Takahiro Shima, Chiaki Kubara, Shun Akamine, Sae Utsumi, Teruhiko Yoshino, Mariko Minami, Masayasu Hayashi, Yayoi Matsuo, Takuro Kuriyama, Reiko Yoneda, Shuichi Taniguchi, Tetsuya Eto
BackgroundPosterior reversible encephalopathy syndrome (PRES) is known as a transfusion‐related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce.Case ReportAn 88‐year‐old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin
-
Updates to Association for the Advancement of Blood and Biotherapies Standards for blood banks and transfusion services, 34th edition Transfusion (IF 2.5) Pub Date : 2024-07-20 Claudia S. Cohn, Christopher Bocquet
-
Making blood immediately available in emergencies Transfusion (IF 2.5) Pub Date : 2024-07-19 John B. Holcomb, Frank K. Butler, Martin A. Schreiber, Audra L. Taylor, Leslie E. Riggs, Jon R. Krohmer, Warren C. Dorlac, Donald H. Jenkins, Daniel B. Cox, Andrew N. Beckett, Kevin C. O'Connor, Jennifer M. Gurney
-
Extracellular vesicles in fresh frozen plasma and cryoprecipitate: Impact on in vitro endothelial cell viability Transfusion (IF 2.5) Pub Date : 2024-07-18 Ji Hui Hwang, John‐Paul Tung, Damien G. Harkin, Robert L. Flower, Natalie M. Pecheniuk
BackgroundTransfusion‐related acute lung injury (TRALI) remains a major contributor to transfusion‐associated mortality. While the pathogenesis of TRALI remains unclear, there is evidence of a role for blood components. We therefore investigated the potential effects of fresh frozen plasma (FFP), cryoprecipitate, and extracellular vesicles (EVs) derived from these blood components, on the viability
-